NEUROHUMORAL ACTIVATION IN CONGESTIVE-HEART-FAILURE

被引:24
作者
MANCIA, G [1 ]
机构
[1] UNIV MILAN,OSPED MAGGIORE,CTR FISIOL CLIN & IPERTENS,CTR AUXOL ITALIANO,I-20122 MILAN,ITALY
关键词
D O I
10.1016/0002-8703(90)90054-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article reviews the evidence that congestive heart failure is accompanied by an increased plasma norepinephrine concentration and that this is due not only to a reduced tissue clearance of the substance but also to a marked increase in sympathetic nerve activity. It also reports data that indicate that the sympathetic activation is associated with an activation of the renin-angiotensin system and an increased plasma level of vasopressin. At which degree of congestive heart failure these phenomena become manifest is not clear, but some studies suggest that the sympathetic and renin-angiotensin systems may be normal in asymptomatic congestive heart failure but already somewhat activated when this condition reaches New York Heart Association class II. There is also evidence that this activation, though initially compensatory, is eventually responsible for a number of adverse cardiovascular effects that account for the negative relationship between this event and survival. Finally, the article discusses the inability of the increased plasma level of atrial natriuretic peptide that characterizes congestive heart failure to offset the adverse effects of the neurohumoral activation and the variable influence of drug treatment on this phenomenon. This is not impossible to achieve, however, because heart transplantation appears to rapidly normalize a major factor in the increased sympathetic activity observed before surgical intervention, that is, impairment of the arterial baroreflex. © 1990.
引用
收藏
页码:1532 / 1537
页数:6
相关论文
共 30 条
[1]  
BAYLISS J, 1987, BRIT HEART J, V57, P17
[2]   AUGMENTATION OF PLASMA NOR-EPINEPHRINE RESPONSE TO EXERCISE IN PATIENTS WITH CONGESTIVE HEART FAILURE [J].
CHIDSEY, CA ;
BRAUNWALD, E ;
HARRISON, DC .
NEW ENGLAND JOURNAL OF MEDICINE, 1962, 267 (13) :650-&
[3]   PLASMA NOREPINEPHRINE AS A GUIDE TO PROGNOSIS IN PATIENTS WITH CHRONIC CONGESTIVE HEART-FAILURE [J].
COHN, JN ;
LEVINE, TB ;
OLIVARI, MT ;
GARBERG, V ;
LURA, D ;
FRANCIS, GS ;
SIMON, AB ;
RECTOR, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (13) :819-823
[4]  
CROZIER IG, 1986, LANCET, V2, P1242
[5]   ABNORMALITIES IN SYSTEMIC NOREPINEPHRINE KINETICS IN HUMAN CONGESTIVE HEART-FAILURE [J].
DAVIS, D ;
BAILY, R ;
ZELIS, R .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (06) :E760-E766
[6]   DEFECTIVE CARDIAC PARASYMPATHETIC CONTROL IN PATIENTS WITH HEART DISEASE [J].
ECKBERG, DL ;
DRABINSKY, M ;
BRAUNWALD, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1971, 285 (16) :877-+
[7]  
EDWARDS B S, 1987, Cardiovascular Drugs and Therapy, V1, P89, DOI 10.1007/BF02125838
[8]   ARTERIAL BAROREFLEX ABNORMALITIES IN HEART-FAILURE - REVERSAL AFTER ORTHOTOPIC CARDIAC TRANSPLANTATION [J].
ELLENBOGEN, KA ;
MOHANTY, PK ;
SZENTPETERY, S ;
THAMES, MD .
CIRCULATION, 1989, 79 (01) :51-58
[9]   NORADRENALINE RELEASE AND SYMPATHETIC NERVOUS-SYSTEM ACTIVITY [J].
ESLER, MD ;
HASKING, GJ ;
WILLETT, IR ;
LEONARD, PW ;
JENNINGS, GL .
JOURNAL OF HYPERTENSION, 1985, 3 (02) :117-129
[10]   SELECTIVE IMPAIRMENT OF BAROREFLEX-MEDIATED VASOCONSTRICTOR RESPONSES IN PATIENTS WITH VENTRICULAR DYSFUNCTION [J].
FERGUSON, DW ;
ABBOUD, FM ;
MARK, AL .
CIRCULATION, 1984, 69 (03) :451-460